glp-1 receptor agonist with dpp-4 inhibitor combination not recommended Differences between agonists and inhibitors Clinical Use of DPP-4 Inhibitors
Description
Multiple neuropsychiatric drugs, including bupropion, quetiapine, and aripiprazole, were included among these medications

Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al

Capsules (non-enteric coated), containing each of the GLP-1 analogues combined with the Axcess delivery formulation (66 mg chenodeoxycholic acid and 33 mg of propyl gallate) were introduced into the intestine after fasting overnight, and blood samples were taken via the saphenous vein for 6 hours thereafter, prior to feeding

doi:10.1124/molpharm.121.000270 3
Development of thermo-sensitive injectable hydrogel with sustained release of doxorubicin: Rheological characterization and in vivo evaluation in rats

Zealand Pharma A/S Altimmune Inc
